Genmab A/S (GNMSF)
439.05
-8.50
(-1.90%)
USD |
OTCM |
Oct 27, 16:00
Genmab Price to Book Value : 4.400 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 4.400 |
| October 26, 2026 | 4.485 |
| October 23, 2026 | 4.485 |
| October 22, 2026 | 3.894 |
| October 21, 2026 | 3.894 |
| October 20, 2026 | 3.894 |
| October 19, 2026 | 3.788 |
| October 16, 2026 | 3.678 |
| October 15, 2026 | 3.678 |
| October 14, 2026 | 3.678 |
| October 13, 2026 | 3.678 |
| October 12, 2026 | 3.678 |
| October 09, 2026 | 3.678 |
| October 08, 2026 | 3.788 |
| October 07, 2026 | 3.788 |
| October 06, 2026 | 3.768 |
| October 05, 2026 | 3.978 |
| October 02, 2026 | 3.558 |
| October 01, 2026 | 3.558 |
| September 30, 2026 | 3.558 |
| September 29, 2026 | 3.558 |
| September 28, 2026 | 3.558 |
| September 25, 2026 | 3.538 |
| September 24, 2026 | 3.475 |
| September 23, 2026 | 3.395 |
| Date | Value |
|---|---|
| September 22, 2026 | 3.508 |
| September 21, 2026 | 3.438 |
| September 18, 2026 | 3.438 |
| September 17, 2026 | 3.438 |
| September 16, 2026 | 3.418 |
| September 15, 2026 | 3.397 |
| September 14, 2026 | 3.300 |
| September 11, 2026 | 3.300 |
| September 10, 2026 | 3.300 |
| September 09, 2026 | 3.300 |
| September 08, 2026 | 3.300 |
| September 04, 2026 | 3.300 |
| September 03, 2026 | 3.388 |
| September 02, 2026 | 3.388 |
| September 01, 2026 | 3.388 |
| August 31, 2026 | 3.388 |
| August 28, 2026 | 3.388 |
| August 27, 2026 | 3.388 |
| August 26, 2026 | 3.377 |
| August 25, 2026 | 3.377 |
| August 24, 2026 | 3.284 |
| August 21, 2026 | 3.377 |
| August 20, 2026 | 3.357 |
| August 19, 2026 | 3.207 |
| August 18, 2026 | 3.207 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascendis Pharma A/S | 9.924 |
| Zealand Pharma A/S | 0.8389 |
| Bavarian Nordic A/S | 1.434 |
| Evaxion AS | 2.774 |
| ACADIA Pharmaceuticals, Inc. | 2.678 |
Price to Book Value Related Metrics
| PE Ratio | 34.68 |
| PS Ratio | 6.773 |
| Price to Free Cash Flow | 31.41 |
| Price | 439.05 |
| Earnings Yield | 2.88% |
| Market Cap | 26.21B |
| Operating PE Ratio | 20.97 |
| Normalized PE Ratio | 28.43 |